Archive · 21 Jun 2025
Axiom-4 Studies Diabetes in Space, Aims for Future Travel
Scientists are sending astronauts to the International Space Station to study how sugar and insulin work in space.
They want to see if being in space changes how the body uses sugar.
Astronauts will use devices to check their blood sugar and also have insulin pens with them.
This research could help people with diabetes by creating better tools to monitor blood sugar and might even let diabetics go to space in the future.
It could also lead to better technology for people who have trouble moving on Earth.
Axiom-4 astronauts are studying glucose and insulin behavior in microgravity during the Suite Ride experiment.
The experiment is a collaboration between Burjeel Holdings and Axiom Space.
Astronauts will use continuous glucose monitors and carry insulin pens.
The research could lead to advancements in wearable technology.
The study aims to potentially enable insulin-dependent diabetics to travel to space.
- Who
- Axiom-4 astronauts and Burjeel Holdings.
- What
- Axiom-4 mission study on insulin behavior in microgravity.
- When
- During the Axiom-4 mission.
- Where
- International Space Station (ISS).
- Why
- To improve diabetes treatments and wearable technology.
Current Regulations
Future Possibilities
Space Travel for Diabetics
Current Regulations
NASA does not allow insulin-dependent diabetics to go to space.
Future Possibilities
This rule might change based on the research.
- Mission Name
- Axiom-4
- Experiment
- Suite Ride
- Lead Organizations
- Burjeel Holdings, Axiom Space
- Focus
- Glucose and Insulin Behavior
- Goal
- Improve diabetes treatment and tech
- Location
- International Space Station (ISS)
